Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Lantern Pharma Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 31 | 32 | +1 |
| Shares | 1.34M | 2.50M | +1.16M (+87.1%) |
| Value | $4.90M | $8.00M | +$3.09M (+63.1%) |
New holders (6)
Institutions that held Lantern Pharma Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BIOS Capital Management, LP | 1,207,709 | $3.85M | 4.09% |
| Voss Capital, LLC | 50,000 | $159.5K | 0.01% |
| Sanctuary Advisors, LLC | 10,000 | $48.1K | 0.00% |
| SBI Securities Co., Ltd. | 2,108 | $6.72K | 0.00% |
| Curio Wealth, LLC | 2,000 | $6.38K | 0.00% |
| Richards, Merrill & Peterson, Inc. | 975 | $3.11K | 0.00% |
Sold out (5)
Institutions that held Lantern Pharma Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Tocqueville Asset Management L.P. | 17,000 | $62.4K |
| Avantax Planning Partners, Inc. | 11,640 | $42.7K |
| Simplex Trading, LLC | 3,104 | $11.0K |
| Indiana Trust & Investment Management CO | 750 | $2.75K |
| Wolff Wiese Magana LLC | 600 | $2.20K |